OBX

12.0001.23%
MB

Michael Briskin

Chairman of Scientific Advisory Board

Dr. Michael Briskin, also known as Mike, Ph.D., is Chairman of the Scientific Advisory Board of Obsidian Therapeutics, Inc. He has years of industry experience in multiple areas of drug discovery, including molecular biology, immunobiology, oncology and inflammation. He is C.S.O & Chair of SAB at Phenomic AI Inc. Dr. Briskin served as a Vice President of Research at Jounce Therapeutics, Inc. Prior to Jounce, he served as a Senior Director of Immunology at Merrimack Pharmaceuticals. Prior to Merrimack, Dr. Briskin served as a Scientific Consultant for Healthcare Ventures. Previously, he served as a Director of Inflammation - Cell Migration at LeukoSite and subsequently Millennium Pharmaceuticals. Dr. Briskin holds a Ph.D. in Molecular Biology and a B.A. in Biology from the University of California, Los Angeles.

Positions